Retinal vascularization rate predicts retinopathy of prematurity and remains unaffected by low-dose bevacizumab treatment Retinal Diseases Share: Do you want to read an article? Please log in or register. E mail Password Login Register for Free Remember me Forgot password? Click here
Do you want to read an article? Please log in or register. E mail Password Login Register for Free Remember me